2620:197:300::/48 RPKI valid
Announced by AS7246 Bristol-Myers Squibb Company.
Origin
| Origin AS | RPKI | Peers seeing it | Sample path | First seen | Last seen |
|---|---|---|---|---|---|
| AS7246 Bristol-Myers Squibb Company | RPKI valid | 35 | 3454988817246 | 2026-09-18 | 2026-10-09 |
RPKI
1 ROA covers this prefix
| ROA prefix | Max length | Authorised origin | Trust anchor | Result for this route |
|---|---|---|---|---|
| 2620:197:300::/48 | /48 | AS7246 | arin | authorises it |
Registry
Who this address space is delegated to, regardless of whether it is routed
- Delegated block
- 2620:197::/36
- RIR
- ARIN
- Country
- 🇺🇸 US
- Status
- allocated
- Allocated
- 2018-07-30
Less specific routes
Announced prefixes that contain this one
Nothing less specific is announced.
More specific routes
0 announced prefixes inside this one
Nothing more specific is announced.